# Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis

> **NCT03328728** · NA · UNKNOWN · sponsor: **Regen Lab SA** · enrollment: 190 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** Cellular Matrix / A-CP HA Kit
- **DEVICE:** Synvisc-One

## Key facts

- **NCT ID:** NCT03328728
- **Lead sponsor:** Regen Lab SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-18
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2019-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03328728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03328728, "Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03328728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*